1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Peptide Synthesis
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Peptide Synthesis Market, by Key Countries
4.2. Peptide Synthesis Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Peptide Synthesis Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Peptide Synthesis Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Peptide Synthesis Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Peptide Synthesis Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Peptide Synthesis Market Analysis 2015-2021 and Forecast 2022-2032, By Product & Service
8.1. Introduction/Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product & Service, 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product & Service, 2022-2032
8.3.1. Reagents
8.3.1.1. Resins
8.3.1.2. Amino Acids
8.3.1.3. Coupling Reagents
8.3.1.4. Dyes and Fluorescent Labeling Reagents
8.3.1.5. Other Reagents
8.3.2. Equipment
8.3.2.1. Peptide Synthesizers
8.3.2.2. Chromatography Equipment
8.3.2.3. Lyophiizers
8.3.3. Services
8.4. Market Attractiveness Analysis By Product & Service
9. Global Peptide Synthesis Market Analysis 2015-2021 and Forecast 2022-2032, By Technology
9.1. Introduction/Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Technology, 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022-2032
9.3.1. Solid-Phase Peptide Synthesis
9.3.2. Solution-Phase Peptide Synthesis
9.3.3. Hybrid & Recombinant Technology
9.4. Market Attractiveness Analysis By Technology
10. Global Peptide Synthesis Market Analysis 2015-2021 and Forecast 2022-2032, By End User
10.1. Introduction/Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2032
10.3.1. Pharmaceutical & Biotechnology Companies
10.3.2. CDMOs & CROs
10.3.3. Academic & Research Institutes
10.4. Market Attractiveness Analysis By End User
11. Global Peptide Synthesis Market Analysis 2015-2021 and Forecast 2022-2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Peptide Synthesis Market Analysis 2015-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By Product & Service
12.4.3. By End User
12.4.4. By Technology
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product & Service
12.5.3. By End User
12.5.4. By Technology
13. Latin America Peptide Synthesis Market Analysis 2015-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Product & Service
13.4.3. By End User
13.4.4. By Technology
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product & Service
13.5.3. By End User
13.5.4. By Technology
14. Europe Peptide Synthesis Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. U.K.
14.4.1.4. Italy
14.4.1.5. Benelux
14.4.1.6. Nordic Countries
14.4.1.7. Rest of Europe
14.4.2. By Product & Service
14.4.3. By End User
14.4.4. By Technology
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product & Service
14.5.3. By End User
14.5.4. By Technology
15. Asia Pacific Peptide Synthesis Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Rest of Asia Pacific
15.4.2. By Product & Service
15.4.3. By End User
15.4.4. By Technology
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product & Service
15.5.3. By End User
15.5.4. By Technology
16. Middle East and Africa Peptide Synthesis Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. South Africa
16.4.1.3. Turkey
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Product & Service
16.4.3. By End User
16.4.4. By Technology
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product & Service
16.5.3. By End User
16.5.4. By Technology
17. Key Countries Peptide Synthesis Market Analysis 2015-2021 and Forecast 2022-2032
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Peptide Synthesis Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.2.2.1. By Product & Service
17.2.2.2. By End User
17.2.2.3. By Technology
17.3. Canada Peptide Synthesis Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.3.2.1. By Product & Service
17.3.2.2. By End User
17.3.2.3. By Technology
17.4. Mexico Peptide Synthesis Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.4.2.1. By Product & Service
17.4.2.2. By End User
17.4.2.3. By Technology
17.5. Brazil Peptide Synthesis Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.5.2.1. By Product & Service
17.5.2.2. By End User
17.5.2.3. By Technology
17.6. Germany Peptide Synthesis Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.6.2.1. By Product & Service
17.6.2.2. By End User
17.6.2.3. By Technology
17.7. France Peptide Synthesis Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.7.2.1. By Product & Service
17.7.2.2. By End User
17.7.2.3. By Technology
17.8. Italy Peptide Synthesis Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.8.2.1. By Product & Service
17.8.2.2. By End User
17.8.2.3. By Technology
17.9. BENELUX Peptide Synthesis Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.9.2.1. By Product & Service
17.9.2.2. By End User
17.9.2.3. By Technology
17.10. UK Peptide Synthesis Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.10.2.1. By Product & Service
17.10.2.2. By End User
17.10.2.3. By Technology
17.11. Nordic Countries Peptide Synthesis Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.11.2.1. By Product & Service
17.11.2.2. By End User
17.11.2.3. By Technology
17.12. China Peptide Synthesis Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.12.2.1. By Product & Service
17.12.2.2. By End User
17.12.2.3. By Technology
17.13. Japan Peptide Synthesis Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.13.2.1. By Product & Service
17.13.2.2. By End User
17.13.2.3. By Technology
17.14. South Korea Peptide Synthesis Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.14.2.1. By Product & Service
17.14.2.2. By End User
17.14.2.3. By Technology
17.15. GCC Countries Peptide Synthesis Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.15.2.1. By Product & Service
17.15.2.2. By End User
17.15.2.3. By Technology
17.16. South Africa Peptide Synthesis Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.16.2.1. By Product & Service
17.16.2.2. By End User
17.16.2.3. By Technology
17.17. Turkey Peptide Synthesis Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.17.2.1. By Product & Service
17.17.2.2. By End User
17.17.2.3. By Technology
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. GENSCRIPT BIOTECH CORPORATION
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. THERMO FISHER SCIENTIFIC
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. MERCK KGAA
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. BACHEM HOLDING AG
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. KANEKA CORPORATION
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. BIOTAGE AB
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Strategy Overview
19.3.7. SYNGENE INTERNATIONAL LIMITED
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Strategy Overview
19.3.8. MESA LABORATORIES, INC
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Strategy Overview
19.3.9. CEM CORPORATION
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Sales Footprint
19.3.9.4. Strategy Overview
19.3.10. PROTEOGENIX
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Sales Footprint
19.3.10.4. Strategy Overview
